49 results
8-K
EX-99.1
CRVS
Corvus Pharmaceuticals Inc
6 May 24
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
4:01pm
believes the inhibition of specific molecular targets in T cells may be of therapeutic benefit for patients with cancers, including solid tumors
8-K
EX-99.1
CRVS
Corvus Pharmaceuticals Inc
19 Mar 24
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:02pm
targets in T cells may be of therapeutic benefit for patients with cancers, including solid tumors, and in patients with autoimmune and allergic diseases
8-K
EX-99.1
CRVS
Corvus Pharmaceuticals Inc
7 Nov 23
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
4:03pm
T cells are involved in the pathogenesis of many autoimmune and allergic diseases. The Company believes the inhibition of specific molecular targets
8-K
EX-99.1
CRVS
Corvus Pharmaceuticals Inc
6 Sep 23
Other Events
7:39pm
the inhibition of specific molecular targets in T cells may be of therapeutic benefit for patients with cancers, including solid tumors
8-K
EX-99.1
pr1 lzx0vr0j45
8 Aug 23
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
4:01pm
8-K
EX-99.1
rbdrwefu95iphu1x
8 May 23
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results
4:01pm
8-K
EX-99.1
q3lp xzjgl
3 Nov 22
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results
4:06pm
8-K
EX-99.1
uvthk 51n87hs3ttcxzg
8 Aug 22
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results
4:05pm
8-K
EX-99.1
xg2 xrdf5
5 May 22
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
p7bcl03fwc8 85
10 Mar 22
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:06pm
8-K
EX-99.1
vyavcmx09i94e81vlj3v
1 Nov 21
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2021 Financial Results
4:07pm
8-K
EX-99.1
lg2x1gw4se ehcz9
2 Aug 21
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results
4:10pm
8-K
EX-99.1
fma5u2gj5a5i
15 Jul 21
Results of Operations and Financial Condition
4:07pm
8-K
EX-99.1
a85h41p6d77tne
29 Apr 21
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results
4:08pm